# Tymlos

NDC: 70539-001
Generic name: abaloparatide
Labeler / Manufacturer: Radius Health, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20170501

FDA application: NDA208743

## Active ingredients

- ABALOPARATIDE: 3.12 mg/1.56mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70539-001"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70539-001
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=712143d9-e21e-4013-bb3b-3426a21060a8